IM Cannabis (IMCC) Deferred Taxes (2020 - 2026)
IM Cannabis' (IMCC) quarterly Deferred Taxes came in at -$29897.4 in Q1 2026, down 7.25% year-on-year from -$32234.1 in Q1 2025, and up 22.79% quarter-over-quarter from -$38722.7 in Q4 2025.
IM Cannabis (IMCC) Deferred Taxes (2020 - 2026) Analysis & Trends
IM Cannabis' Deferred Taxes history runs 7 years deep, the most recent figure standing at -$29897.4 for Q1 2026.
- On a quarterly basis, Deferred Taxes fell 7.25% year-over-year to -$29897.4 in Q1 2026; TTM through Mar 2026 was -$120014.3, a 37.99% decrease from a year earlier, with the FY2025 full-year figure at -$118319.2, down 8.0% from the prior year.
- Deferred Taxes improved to -$29897.4 in Q1 2026 per IMCC's latest filing, from -$38722.7 in the prior quarter.
- Across five years, Deferred Taxes topped out at $436314.1 in Q4 2023 and bottomed at -$1.0 million in Q2 2022.
- The 5-year median for Deferred Taxes is -$28868.5 (2025), against an average of -$133751.8.
- Across the five-year window, Deferred Taxes plunged 767.15% in 2022 and surged 229.71% in 2023, its largest moves.
- Year by year, Deferred Taxes stood at -$849418.5 in 2022, then soared by 151.37% to $436314.1 in 2023, then plunged by 101.97% to -$8590.2 in 2024, then tumbled by 350.78% to -$38722.7 in 2025, then climbed by 22.79% to -$29897.4 in 2026.
- Per Business Quant, the three latest IMCC Deferred Taxes figures stand at -$29897.4 (Q1 2026), -$38722.7 (Q4 2025), and -$22525.7 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -22.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 34.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 25.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -69.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -61.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | IM Cannabis | 591,792.44 | -193,562.09 | 1.03 Mn | -29,897.43 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29,897.43 |
| Dec 31, 2025 | -38,722.66 |
| Sep 30, 2025 | -22,525.69 |
| Jun 30, 2025 | -28,868.50 |
| Mar 31, 2025 | -27,876.66 |
| Dec 31, 2024 | -8,590.19 |
| Sep 30, 2024 | -22,724.66 |
| Jun 30, 2024 | -27,783.34 |
| Mar 31, 2024 | -51,205.81 |
| Dec 31, 2023 | 436,314.10 |
| Sep 30, 2023 | 14,918.61 |
| Jun 30, 2023 | -52,111.67 |
| Mar 31, 2023 | -110,954.45 |
| Dec 31, 2022 | -849,418.49 |
| Sep 30, 2022 | -11,501.19 |
| Jun 30, 2022 | -1.01 Mn |
| Mar 31, 2022 | -427,895.67 |
| Dec 31, 2021 | 234,827.48 |
| Sep 30, 2021 | -330,474.27 |
| Jun 30, 2021 | 152,129.58 |